Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Many research paper titles in dermatology journals lack scientific precision.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Biologics for severe asthma have known side effects, but some new risks need more study.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Apremilast shows promise for several skin conditions but needs more research.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

A child with low platelets and anemia was later found to have lupus.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A unique case showed a rare combination of two types of lichen planus on the face.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

A woman's chronic head pain after hair transplant surgery was cured by removing a post-traumatic neuroma.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Kidney transplant patients often have skin issues, mainly infections.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Both treatments for alopecia areata showed similar modest effectiveness.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

A woman with lupus had rare severe symptoms but improved with treatment.